Viewing StudyNCT04648930



Ignite Creation Date: 2024-05-06 @ 3:29 PM
Last Modification Date: 2024-10-26 @ 1:50 PM
Study NCT ID: NCT04648930
Status: COMPLETED
Last Update Posted: 2023-08-23
First Post: 2020-11-24

Brief Title: Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged 12 Years and 18 Years Whose Symptoms Were Inadequately Controlled Despite to Conventional Therapies
Sponsor:
Organization: Novartis

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 50
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
70448
Who Masked List: